Mylan's (MYL) Price Target Reduced to $65 at Deutsche Bank
Get Alerts MYL Hot Sheet
Rating Summary:
17 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 18
Join SI Premium – FREE
Deutsche Bank maintained a Buy rating on Mylan (NASDAQ: MYL) but cut its price target to $65.00 (from $82.00). The change reflects standalone valuation after Teva Pharma (NYSE: TEVA) earlier withdrew its agreement to acquired the company.
"Following TEVA’s announced plan to acquire Allergan Generics rather than MYL, we are moving back to a standalone valuation basis for MYL, which takes our PT to $65 (from $82, which was TEVA’s initial offer)," said analyst Gregg Gilbert.
"We are sticking with our Buy rating, as our target for standalone MYL supports upside from here. We note that our estimates and thesis could be influenced by the outcome of MYL’s planned acquisition of PRGO (which PRGO has rejected). The next key step in that process will be a vote by MYL’s shareholders on the proposed acquisition; MYL indicated this morning that it expects the vote to occur in the next several weeks. In the short-term, it is worth considering that ABT owns 70mn shares (14.2%) and TEVA owns 22.6mn shares (4.6%), and with neither company likely to be a long-term investor, those shares represent an overhang. In addition, it will be interesting to see if interest in PRGO from other parties emerges in the coming weeks," he added.
For an analyst ratings summary and ratings history on Mylan click here. For more ratings news on Mylan click here.
Shares of Mylan closed at $65.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Maxim Group Starts The Lovesac Co. (LOVE) at Buy
- Travelers (TRV) PT Lowered to $202 at Goldman Sachs
- Loop Capital Starts Samsara Inc (IOT) at Buy, 'Play on AI, ML, & IoT Tech Themes in Asset Intensive Industries'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Deutsche Bank, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!